Bioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteers
Open Access
- 4 December 2009
- journal article
- research article
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 9 (1) , 19
Abstract
Background: The aim of this study was to compare the pharmacokinetic properties of sodium ibuprofen and ibuprofen acid incorporating poloxamer with standard ibuprofen acid tablets. Methods: Twenty-two healthy volunteers were enrolled into this randomised, single-dose, 3-way crossover, open-label, single-centre, pharmacokinetic study. After 14 hours' fasting, participants received a single dose of 2 × 200 mg ibuprofen acid tablets (standard ibuprofen), 2 × 256 mg ibuprofen sodium dihydrate tablets (sodium ibuprofen; each equivalent to 200 mg ibuprofen acid) and 2 × 200 mg ibuprofen acid incorporating 60 mg poloxamer 407 (ibuprofen/poloxamer). A washout period of 2-7 days separated consecutive dosing days. On each of the 3 treatment days, blood samples were collected post dose for pharmacokinetic analyses and any adverse events recorded. Plasma concentration of ibuprofen was assessed using a liquid chromatographic-mass spectrometry procedure in negative ion mode. A standard statistical ANOVA model, appropriate for bioequivalence studies, was used and ratios of 90% confidence intervals (CIs) were calculated. Results: Tmax for sodium ibuprofen was less than half that of standard ibuprofen (median 35 min vs 90 min, respectively; P = 0.0002) and Cmax was significantly higher (41.47 μg/mL vs 31.88 μg/mL; ratio test/reference = 130.06%, 90% CI 118.86-142.32%). Ibuprofen/poloxamer was bioequivalent to the standard ibuprofen formulation, despite its Tmax being on average 20 minutes shorter than standard ibuprofen (median 75 mins vs 90 mins, respectively; P = 0.1913), as the ratio of test/reference = 110.48% (CI 100.96-120.89%), which fell within the 80-125% limit of the CPMP and FDA guidelines for bioequivalence. The overall extent of absorption was similar for the three formulations, which were all well tolerated. Conclusion: In terms of Tmax, ibuprofen formulated as a sodium salt was absorbed twice as quickly as from standard ibuprofen acid. The addition of poloxamer to ibuprofen acid did not significantly affect absorption.Keywords
This publication has 19 references indexed in Scilit:
- Onset of analgesia with sodium ibuprofen, ibuprofen acid incorporating poloxamer and acetaminophen—a single-dose, double-blind, placebo-controlled study in patients with post-operative dental painEuropean Journal of Clinical Pharmacology, 2009
- Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407Archives of Pharmacal Research, 2008
- Ibuprofen arginate provides effective relief from postoperative dental pain with a more rapid onset of action than ibuprofenEuropean Journal of Clinical Pharmacology, 2002
- Comparative Pharmacokinetics of Two Fast-Dissolving Oral Ibuprofen Formulations and a Regular-Release Ibuprofen Tablet in Healthy VolunteersClinical Drug Investigation, 2001
- Clinical Pharmacokinetics of IbuprofenClinical Pharmacokinetics, 1998
- Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthasesBritish Journal of Pharmacology, 1997
- Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in manBiopharmaceutics & Drug Disposition, 1990
- The correlation between blood levels of ibuprofen and clinical analgesic responseClinical Pharmacology & Therapeutics, 1986
- Naproxen Sodium in the Treatment of MigraineCephalalgia, 1985
- Pharmacokinetics of IbuprofenThe American Journal of Medicine, 1984